Home LiteratureArticle Details
PMID: 90271 Published · ppublish English Case Reports Journal Article

Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril.

Lancet (London, England) ·Vol. 2 ·No. 8143 ·1979-09-22 ·Pages 606-9

Atkinson AB, Davies DL, Leckie B, Morton JJ, Brown JJ, Fraser R, Lever AF, Robertson JI

Abstract

Malignant hypertension with severe hyponatraemia, hypokalaemia, depletion of sodium and potassium, and elevated blood levels of renin, angiotensin I, angiotensin II, aldosterone, and arginine vasopressin developed in a woman with renal-artery occlusion. Plasma angiotensin II was disproportionately high in relation to exchangeable sodium. Captopril, by inhibiting conversion of angiotensin I to angiotensin II, further elevated the blood levels of renin and angiotensin I but corrected all other abnormalities. Unilateral nephrectomy was subsequently curative.

MeSH Terms
Aldosterone/blood Angiotensin I/blood Angiotensin II/antagonists & inhibitors,blood Arginine Vasopressin/blood Blood Pressure/drug effects Captopril/therapeutic use Female Humans Hypertension, Malignant/drug therapy Hyponatremia/drug therapy Middle Aged Potassium/blood Proline/analogs & derivatives Renal Artery Obstruction/physiopathology Renin/blood Syndrome
Chemicals
Angiotensin II Arginine Vasopressin Aldosterone Angiotensin I Proline Captopril Renin Potassium
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Atkinson A B
Davies D L
Leckie B
Morton J J
Brown J J
Fraser R
Lever A F
Robertson J I
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1979-09-22
Pages
606-9
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com